| OPB-31121 |
NCT01029509 |
Terminated |
Phase 1 |
Study to Assess OPB-31121 in Advanced Leukemias or Myelodysplastic Syndromes |
Leukemia |
https://ClinicalTrials.gov/show/NCT01029509 |
| OPB-31121 |
NCT00955812 |
Completed |
Phase 1 |
STAT3 Inhibitor for Solid Tumors |
Advanced Cancer|Solid Tumor |
https://ClinicalTrials.gov/show/NCT00955812 |
| OPB-31121 |
NCT00511082 |
Unknown status |
Phase 1 |
Phase 1 Study of OPB-31121 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma |
Non-Hodgkin's Lymphoma(NHL)|Multiple Myeloma(MM) |
https://ClinicalTrials.gov/show/NCT00511082 |
| OPB-31121 |
NCT01406574 |
Completed |
Phase 1|Phase 2 |
Phase I/II Study of OPB-31121 in Patients With Progressive Hepatocellular Carcinoma |
Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT01406574 |
| OPB-31121 |
NCT00657176 |
Unknown status |
Phase 1 |
An Open-Label Phase-1 Study of OPB-31121 in Patients With Advanced Solid Tumors |
Solid Tumor |
https://ClinicalTrials.gov/show/NCT00657176 |
